{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:11:57Z","timestamp":1788336717665,"version":"build-2803163510"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ajem.2022.06.009","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T12:02:10Z","timestamp":1654689730000},"page":"210-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A retrospective review of implementation of an inhaled epoprostenol protocol in the emergency department"],"prefix":"10.1016","volume":"58","author":[{"given":"David","family":"Toomey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan D.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajem.2022.06.009_bb0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1213\/ANE.0000000000002138","article-title":"Aerosolized vasodilators for the treatment of pulmonary hypertension in cardiac surgical patients: a systematic review and Meta-analysis","volume":"125","author":"Elmi-sarabi","year":"2017","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.ajem.2022.06.009_bb0010","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1345\/aph.1R540","article-title":"Efficacy, safety, and medication errors associated with the use of inhaled epoprostenol for adults with acute respiratory distress syndrome: a pilot study","volume":"47","author":"Dunkley","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.ajem.2022.06.009_bb0015","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jcrc.2013.03.006","article-title":"Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients","volume":"28","author":"Torbic","year":"2013","journal-title":"J Crit Care"},{"issue":"6","key":"10.1016\/j.ajem.2022.06.009_bb0020","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1378\/chest.14-3161","article-title":"The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysis","volume":"147","author":"Fuller","year":"2015","journal-title":"Chest."},{"issue":"4","key":"10.1016\/j.ajem.2022.06.009_bb0025","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jtcvs.2003.11.035","article-title":"Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery","volume":"127","author":"De Wet","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.ajem.2022.06.009_bb0030","doi-asserted-by":"crossref","DOI":"10.1177\/2045894019899775","article-title":"Pulmonary vasodilation in acute pulmonary embolism - a systematic review","volume":"10","author":"Lyhne","year":"2020","journal-title":"Pulm Circ"},{"issue":"8","key":"10.1016\/j.ajem.2022.06.009_bb0035","first-page":"660","article-title":"A case of severe pulmonary hypertension associated with COPD treated with epoprostenol","volume":"46","author":"Ishikawa","year":"2008","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"issue":"6","key":"10.1016\/j.ajem.2022.06.009_bb0040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.annemergmed.2015.07.525","article-title":"Pulmonary hypertension and right ventricular failure in emergency medicine","volume":"66","author":"Wilcox","year":"2015","journal-title":"Ann Emerg Med"},{"issue":"9","key":"10.1016\/j.ajem.2022.06.009_bb0045","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2022.06.009_bb0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcrc.2020.11.002","article-title":"Vasopressor dose equivalence: a scoping review and suggested formula","volume":"61","author":"Goradia","year":"2021","journal-title":"J Crit Care"},{"issue":"25 Suppl","key":"10.1016\/j.ajem.2022.06.009_bb0055","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ajem.2022.06.009_bb0060","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.4187\/respcare.02939","article-title":"Predictors of outcome in 216 subjects with ARDS treated with inhaled epoprostenol","volume":"59","author":"Pacheco","year":"2014","journal-title":"Respir Care"},{"issue":"10","key":"10.1016\/j.ajem.2022.06.009_bb0065","article-title":"Evaluation of the efficacy and safety of inhaled Epoprostenol and inhaled nitric oxide for refractory hypoxemia in patients with coronavirus disease 2019","volume":"2","author":"DeGrado","year":"2020","journal-title":"Crit Care Explor"},{"issue":"3","key":"10.1016\/j.ajem.2022.06.009_bb0070","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/0885066620976525","article-title":"Responsiveness of inhaled epoprostenol in respiratory failure due to COVID-19","volume":"36","author":"Sonti","year":"2021","journal-title":"J Intensive Care Med"},{"issue":"8","key":"10.1016\/j.ajem.2022.06.009_bb0075","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.4187\/respcare.05268","article-title":"Severity of hypoxemia and other factors that influence the response to aerosolized prostacyclin in ARDS","volume":"62","author":"Kallet","year":"2017","journal-title":"Respir Care"},{"issue":"6","key":"10.1016\/j.ajem.2022.06.009_bb0080","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4187\/respcare.03927","article-title":"Inhaled therapies for pulmonary hypertension","volume":"60","author":"Hill","year":"2015","journal-title":"Respir Care"},{"issue":"7","key":"10.1016\/j.ajem.2022.06.009_bb0085","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/0885066620917658","article-title":"Changes in oxygen saturation and mean arterial pressure with inhaled epoprostenol in transport","volume":"36","author":"Richards","year":"2021","journal-title":"J Intensive Care Med"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572200376X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572200376X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:03:37Z","timestamp":1760025817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073567572200376X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":17,"alternative-id":["S073567572200376X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2022.06.009","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A retrospective review of implementation of an inhaled epoprostenol protocol in the emergency department","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2022.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}